期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 65, 期 22, 页码 15391-15415出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.2c01350
关键词
-
资金
- State of Florida via the Florida Department of Health [8BC05]
- SBMRI at Lake Nona
- UCF College of Medicine
This study discovered a compound that potentiates the ODC inhibitor DFMO and identified FUBP1 as its target. The compound works synergistically with DFMO to limit cell growth and affects the expression levels of FUBP1-associated genes and intracellular polyamines.
Polyamine biosynthesis is regulated by ornithine decarboxylase (ODC), which is transcriptionally activated by c-Myc. A large library was screened to find molecules that potentiate the ODC inhibitor, difluoromethylornithine (DFMO). Anthranilic acid derivatives were identified as DFMO adjunct agents. Further studies identified the far upstream binding protein 1 (FUBP1) as the target of lead compound 9. FUBP1 is a single-stranded DNA/RNA binding protein and a master controller of specific genes including c-Myc and p21. We showed that 9 does not inhibit 3H-spermidine uptake yet works synergistically with DFMO to limit cell growth in the presence of exogenous spermidine. Compound 9 was also shown to inhibit the KH4 FUBP1-FUSE interaction in a gel shift assay, bind to FUBP1 in a ChIP assay, reduce both c-Myc mRNA and protein expression, increase p21 mRNA and protein expression, and deplete intracellular polyamines. This promising hit opens the door to new FUBP1 inhibitors with increased potency.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据